In conversation with... Michael Heneka

from Listen to The Lancet · host The Lancet

Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease.

Episode metadata supplied by the publisher feed · Published Jan 10, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Michael Heneka

0:00 21:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 21 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on January 10, 2025.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!